Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions
Opioid Tapering
Interventions
BEHAVIORAL

Patient-centered Decision Aid to support long-term opioid therapy tapering

Earlier aims of this study developed a patient-centered Decision Aid (DA) that uses stories of people who benefited from discontinuing and clear explanations of evidence for key choices to decrease stigma; empower patients; increase engagement and productive interaction with providers in decision making; and reduce fear, anger and anxiety about tapering. The DA will be designed to support conversations that providers often find challenging and help providers maintain patient trust and satisfaction. Participants in the pilot test will be asked to: 1) complete a pre-DA survey, 2) review the DA, 3) have a guided conversation with a trained study interventionist with a behavioral health background who is trained on how to use the DA, and 4) complete a post-DA survey.

Trial Locations (1)

98101

Kaiser Permanente Washington Health Research Institute, Seattle

All Listed Sponsors
collaborator

University of Arkansas

OTHER

collaborator

University of Washington

OTHER

lead

Kaiser Permanente

OTHER

NCT07202026 - Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot | Biotech Hunter | Biotech Hunter